- Home
- GYRE vs CARS Comparison
GYRE vs CARS Comparison
Compare GYRE & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- CARS
- Stock Information
- Founded
- GYRE 2002
- CARS 1998
- Country
- GYRE United States
- CARS United States
- Employees
- GYRE N/A
- CARS N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- CARS Motor Vehicles
- Sector
- GYRE Health Care
- CARS Consumer Discretionary
- Exchange
- GYRE Nasdaq
- CARS Nasdaq
- Market Cap
- GYRE 755.7M
- CARS 692.6M
- IPO Year
- GYRE N/A
- CARS 2017
- Fundamental
- Price
- GYRE $8.19
- CARS $11.66
- Analyst Decision
- GYRE Strong Buy
- CARS Strong Buy
- Analyst Count
- GYRE 2
- CARS 5
- Target Price
- GYRE $17.00
- CARS $17.90
- AVG Volume (30 Days)
- GYRE 60.0K
- CARS 916.2K
- Earning Date
- GYRE 11-07-2025
- CARS 11-06-2025
- Dividend Yield
- GYRE N/A
- CARS N/A
- EPS Growth
- GYRE N/A
- CARS N/A
- EPS
- GYRE 0.04
- CARS 0.47
- Revenue
- GYRE $107,265,000.00
- CARS $719,767,000.00
- Revenue This Year
- GYRE $15.25
- CARS $2.52
- Revenue Next Year
- GYRE $33.14
- CARS $3.00
- P/E Ratio
- GYRE $211.54
- CARS $24.81
- Revenue Growth
- GYRE 2.13
- CARS 0.20
- 52 Week Low
- GYRE $6.11
- CARS $9.56
- 52 Week High
- GYRE $19.00
- CARS $20.47
- Technical
- Relative Strength Index (RSI)
- GYRE 59.01
- CARS 57.12
- Support Level
- GYRE $7.12
- CARS $11.12
- Resistance Level
- GYRE $7.42
- CARS $11.72
- Average True Range (ATR)
- GYRE 0.34
- CARS 0.50
- MACD
- GYRE 0.04
- CARS 0.17
- Stochastic Oscillator
- GYRE 94.82
- CARS 73.64
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
About CARS Cars.com Inc.
Cars.com Inc is an online destination for buying and selling new and used vehicles. It is an audience-driven technology company empowering the automotive industry. The company brands include Dealer Inspire, DealerRater, FUEL, Accu-Trade, PickupTrucks.com, CreditIQ, and NewCars.com., websites directed towards different consumer segments.